NEW YORK, June 1, 2023 /PRNewswire/ — Levi & Korsinsky notifies investors that it has commenced an investigation of Phathom Pharmaceuticals, Inc. (“Phathom”) (NASDAQ: PHAT) concerning possible violations of federal securities laws. On August 2, 2022, before market hours, Phathom issued a press release entitled “Phathom Pharmaceuticals Reports Second Quarter…Read More
PHAT Levi Korsinsky LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Phathom Pharmaceuticals Inc MarketScreener
